Skip to main content
Table of Contents
Print

Can Cannabis Reduce Therapy Drop-Out in Anxiety Patients? 

Author: Julia Sutton, MSc | Reviewed by: Dr. Clarissa Morton, PharmD

Using cannabis for therapy retention in anxiety  may support patients in staying consistent with their treatment plans. By easing anxiety, it encourages adherence, minimises reduced avoidance, and boosts overall treatment success. This approach can make therapy more approachable and productive for those who struggle to stay engaged. 

Understanding Cannabis for Therapy Retention 

Incorporating cannabis for therapy retention in anxiety can create a calmer mental state that makes therapy less intimidating. This can encourage patients to attend sessions consistently and participate more openly. 

Adherence 

Cannabis can improve adherence by lowering anxiety before sessions, helping patients follow through with scheduled appointments. 

Reduced Avoidance 

When used thoughtfully, cannabis for therapy retention in anxiety can address reduced avoidance by supporting emotional comfort and allowing patients to approach difficult topics with greater confidence. 

Treatment Success 

Supporting regular participation increases the likelihood of treatment success, as patients engage more fully in therapeutic work. 

Selecting the right strain and dose is crucial to ensure cannabis for therapy retention in anxiety improves focus rather than causing sedation or distraction. 

If you’re exploring cannabis treatment options for anxiety disorders, visit providers like LeafEase for personalised consultations and guidance tailored to your needs. 

For a deeper dive into the science, diagnosis, and full treatment landscape, read our complete guide to Medical Cannabis and anxiety disorders . 

Julia Sutton, MSc
Author

Julia Sutton is a clinical psychologist with a Master’s in Clinical Psychology and experience providing psychological assessment and therapy to adolescents and adults. Skilled in CBT, client-centered therapy, and evidence-based interventions, she has worked with conditions including depression, anxiety, bipolar disorder, and conversion disorder. She also has experience in child psychology, conducting psycho-educational evaluations and developing tailored treatment plans to improve learning and well-being.

All qualifications and professional experience stated above are authentic and verified by our editorial team. However, pseudonym and image likeness are used to protect the author's privacy. 

Dr. Clarissa Morton, PharmD
Reviewer

Dr. Clarissa Morton is a licensed pharmacist with a Doctor of Pharmacy degree and experience across hospital, community, and industrial pharmacy. She has worked in emergency, outpatient, and inpatient pharmacy settings, providing patient counseling, dispensing medications, and ensuring regulatory compliance. Alongside her pharmacy expertise, she has worked as a Support Plan & Risk Assessment (SPRA) officer and in medical coding, applying knowledge of medical terminology, EMIS, and SystmOne software to deliver accurate, compliant healthcare documentation. Her skills span medication safety, regulatory standards, healthcare data management, and statistical reporting.

All qualifications and professional experience stated above are authentic and verified by our editorial team. However, pseudonym and image likeness are used to protect the reviewers's privacy. 

Categories